Clinical Trial Update: Outcome and Treatment Quality Study of Tolvaptan to Treat Hyponatremia in Patients With Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating tolvaptan for hyponatremia in heart failure has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hyponatremia

Drugs mentioned

• tolvaptan (tolvaptan)

Snippet

Sponsor: Korea Otsuka Pharmaceutical Co., Ltd. | Conditions: Heart Failure With Hyponatremia | Phase 4 | Status: TERMINATED